High frequency of brain metastases after adjuvant therapy for high‐risk melanoma

The incidence of CNS progression in patients with high‐risk regional melanoma (stages IIIAN2a‐IIIC) is not well characterized. Data from the S0008 trial provided an opportunity to examine the role of CNS progression in treatment failure and survival. All patients were surgically staged. Following wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Samlowski, Wolfram E., Moon, James, Witter, Merle, Atkins, Michael B., Kirkwood, John M., Othus, Megan, Ribas, Antoni, Sondak, Vernon K., Flaherty, Lawrence E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673911/
https://www.ncbi.nlm.nih.gov/pubmed/28994212
http://dx.doi.org/10.1002/cam4.1223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673911/
https://www.ncbi.nlm.nih.gov/pubmed/28994212
http://dx.doi.org/10.1002/cam4.1223

Ejemplares similares